Published 2 days ago • loading... • Updated 7 hours ago

Biogen’s Investigational Tau-Targeting Therapy BIIB080 Receives FDA Fast Track Designation for the Treatment of Alzheimer’s Disease

Summary by The Toronto Star

CAMBRIDGE, Mass., April 02, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to BIIB080, an investigational antisense oligonucleotide (ASO) therapy targeting tau, for the treatment…

10 Articles

All

Left

Center

Right

Punch Newspapers

Lean Left

Researcher identifies safer alternatives for Alzheimer’s treatment

A Nigerian researcher, Isreal Onifade, has identified plant compounds that could help in the treatment of Alzheimer’s disease. Onifade’s study found that certain plant alkaloids can block β-secretase, an enzyme linked to the buildup of harmful plaques in the brain. These plaques, he said in a statement he signed on Wednesday, are a major cause

1 day ago

Read Full Article

Financial Post

Lean Right

Biogen's Investigational Tau-Targeting Therapy BIIB080 Receives FDA Fast Track Designation for the Treatment of Alzheimer's Disease

“We are encouraged by the FDA’s Fast Track designation for BIIB080, which highlights the urgent need for innovative treatments targeting tau pathology in Alzheimer’s disease,” said Priya Singhal, M.D., M.P.H., Head of Development at Biogen. “Alzheimer’s is a complex and fatal disease that we believe will require multiple therapeutic approaches to address its diverse pathologies. BIIB080, an investigational antisense therapy, is a differentiated …

1 day ago·Canada

Read Full Article

Orangeville

Reposted by

The Toronto Star

Lean Left

Biogen’s Investigational Tau-Targeting Therapy BIIB080 Receives FDA Fast Track Designation for the Treatment of Alzheimer’s Disease

2 days ago·Orangeville, Canada

Read Full Article

News Bulletin 247

Two herbs can reverse Alzheimer's symptoms - News Bulletin 247

Scientists have begun to develop a new treatment for this condition, using ingredients found in two herbs Two herbs that are most likely in our home closet can reverse the symptoms of Alzheimer’s disease, a new study notes. Scientists have begun to develop a new treatment for this condition, using ingredients found in rosemary and sage, creating a compound. The carnosic acid -the compound found in both herbs -which has antioxidant and anti -infl…

7 hours ago

Read Full Article

researchsquare.com

Targeting Fyn kinase for alleviation of cognitive impairment in Streptozocin-induced Alzheimer’s disease in mice by Loperamide; An Experimental and In silico analysis

Alzheimer’s disease (AD) is a complex, progressive neurodegenerative disorder that leads to irreversible deterioration of neuronal cells over time. It is the most frequent cause of dementia in elderly individuals globally. Current treatment drugs exhibit a modest effect on AD patients. Fyn kin...

10 hours ago

Read Full Article

Pharmaceutical Business review

FDA grants fast track status to Biogen’s BIIB080 for Alzheimer's

This status is aimed at facilitating the development and speeding up the review process for drugs that address serious conditions and fill unmet medical needs. Biogen development head The post FDA grants fast track status to Biogen’s BIIB080 for Alzheimer’s appeared first on Pharmaceutical Business review.

12 hours ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year